Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
Haojie Zhang, Yuying Wang, Chi Chen, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 13, pp. 1593-1601
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Navigating the Nomenclature of Liver Steatosis: Transitioning from NAFLD to MAFLD and MASLD - Understanding Affinities and Differences
Apichat Kaewdech, Pimsiri Sripongpun
Deleted Journal (2024) Vol. 76, Iss. 4, pp. 234-243
Open Access | Times Cited: 2
Leisure Sedentary Behavior, Physical Activities, and Cardiovascular Disease Among Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease
Hanzhang Wu, Jiahe Wei, W. Chen, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 2
Metabolically associated fatty liver disease – a disease of the 21st century: A review
И. В. Маев, Д. Н. Андреев, Yu. A. Kucheryavyy
Consilium Medicum (2022) Vol. 24, Iss. 5, pp. 325-332
Open Access | Times Cited: 12
Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction–associated fatty liver disease: Results from two prospective cohorts
Yixiao Zhang, Tingjing Zhang, Yashu Liu, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 10, pp. 102873-102873
Closed Access | Times Cited: 6
Lipid nanoparticle encapsulated oleic acid induced lipotoxicity to hepatocytes via ROS overload and the DDIT3/BCL2/BAX/Caspases signaling in vitro and in vivo
Yanan Liu, Hongxia Zhu, Tao-Yu Li, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 361-370
Open Access | Times Cited: 1
Epicardial and liver fat implications in albuminuria: a retrospective study
Carolina M. Perdomo, Nerea Martín‐Calvo, Ana Ezponda, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Elevated Concurrent Carotid Atherosclerosis Rates in Patients with metabolic dysfunction-associated fatty liver disease (MAFLD) Compared to non-alcoholic fatty liver disease (NAFLD): A Cross-sectional Observational Study
N. Chung, Chiann‐Yi Hsu, Nai-Chen Shih, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 35, Iss. 1, pp. 103767-103767
Closed Access | Times Cited: 1
Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
Mohammad W. Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 477-496
Open Access | Times Cited: 4
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
Jacob George, George Lau, Takumi Kawaguchi, et al.
Hepatology International (2023) Vol. 17, Iss. 3, pp. 546-549
Open Access | Times Cited: 4
The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
Zifeng Yang, Juan Yang, Jingjing Cai, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 6, pp. 157-157
Open Access | Times Cited: 2
Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, et al.
Cureus (2023)
Open Access | Times Cited: 2
Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
Enrico Torre, Sergio Di Matteo, Chiara Martinotti, et al.
ClinicoEconomics and Outcomes Research (2024) Vol. Volume 16, pp. 773-784
Open Access
Economic impact of metabolic dysfunction-associated steatotic liver (MASLD) in Italy. Analysis and perspectives
Enrico Torre, Sergio Di Matteo, Chiara Martinotti, et al.
Research Square (Research Square) (2024)
Open Access
Hepatocardial relationships in non-alcoholic fatty liver disease: issues of epidemiology, diagnosis, prognosis
Renata R. Savzikhanova, Dinara Olegovna Subkhangulova, Е. В. Хазова
Kazan medical journal (2024)
Open Access
MAFLD AND NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?
Rosa Lombardi, Annalisa Cespiati, Paolo Francione, et al.
Metabolism and Target Organ Damage (2021)
Open Access | Times Cited: 3
Comment on “An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD”
Stefano Ciardullo, Gianluca Perseghin
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 12, pp. 2926-2927
Closed Access | Times Cited: 1
Reply
Cheng Han Ng, Ansel Shao Pin Tang, Mark Muthiah
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 12, pp. 2927-2927
Closed Access
The Entanglement between Metabolic Associated Non- Alcoholic Fatty liver Disease and Chronic Kidney Disease Progression is more than just a Strong Correlation. A Narrative Review
Mohamed Ahmed Nasreldin
International Journal of Clinical Nephrology (2022) Vol. 4, Iss. 2, pp. 01-12
Open Access
Toàn văn tập 1 số 3 (2022)
PNT Y dược
Pham Ngoc Thach Journal of Medicine and Pharmacy (2022), Iss. 2022 - Volume 1.3
Open Access
Tỷ lệ và một số đặc điểm bệnh gan nhiễm mỡ liên quan chuyển hóa ở bệnh nhân bị gan nhiễm mỡ tại Bệnh viện Nhân Dân Gia Định
Bảo Vũ Quốc, Vy Nguyễn Ngọc Tường
Pham Ngoc Thach Journal of Medicine and Pharmacy (2022), Iss. 2022 - Volume 1.3
Open Access
Previous Page - Page 2

Scroll to top